1. Metformin use is associated with longer survival in glioblastoma patients with MGMT gene silencing
    Amro H. Mohammad et al, 2023, Journal of Neuro-Oncology CrossRef
  2. The Role of AMPK/mTOR Signaling Pathway in Anticancer Activity of Metformin
    Nikola Chomanicova et al, 2021, Physiological Research CrossRef
  3. Glioma Stem-Like Cells and Metabolism: Potential for Novel Therapeutic Strategies
    Abigail Harland et al, 2021, Frontiers in Oncology CrossRef
  4. Elevated de novo protein synthesis in FMRP-deficient human neurons and its correction by metformin treatment
    Kagistia Hana Utami et al, 2020, Molecular Autism CrossRef
  5. Exploring the Mechanism of Adjuvant Treatment of Glioblastoma Using Temozolomide and Metformin
    Shao-Wei Feng et al, 2022, International Journal of Molecular Sciences CrossRef
  6. The Potential Therapeutic Impact of Metformin in Glioblastoma Multiforme
    Mehdi Sanati et al, 2023, Current Medicinal Chemistry CrossRef
  7. Role of renin angiotensin system inhibitors and metformin in Glioblastoma Therapy: a review
    Sashana Dixon et al, 2024, Cancer Chemotherapy and Pharmacology CrossRef
  8. Exploring the Impact of the Obesity Paradox on Lung Cancer and Other Malignancies
    Lindsay Joyce Nitsche et al, 2022, Cancers CrossRef
  9. Canagliflozin Inhibits Glioblastoma Growth and Proliferation by Activating AMPK
    Kenji Shoda et al, 2023, Cellular and Molecular Neurobiology CrossRef
  10. Frontiers in Anti-Cancer Drug Discovery: Challenges and Perspectives of Metformin as Anti-Angiogenic Add-On Therapy in Glioblastoma
    Laura Guarnaccia et al, 2021, Cancers CrossRef